INBIOGEN Co., Ltd. (KRX:101140)
South Korea
· Delayed Price · Currency is KRW 8,570.00
+310.00 (3.75%)
At close: Apr 29, 2026
INBIOGEN Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 901.7 | 5,716 | 6,089 | 9,290 | 23,152 | Upgrade
|
| Cash & Short-Term Investments | 901.7 | 5,716 | 6,089 | 9,290 | 23,152 | Upgrade
|
| Cash Growth | -84.23% | -6.12% | -34.45% | -59.88% | -70.71% | Upgrade
|
| Accounts Receivable | 4,162 | 3,285 | 4,182 | 5,494 | 6,233 | Upgrade
|
| Other Receivables | 137.41 | 143.02 | 87.24 | 155.77 | 302.59 | Upgrade
|
| Receivables | 4,300 | 3,428 | 4,269 | 5,650 | 6,575 | Upgrade
|
| Inventory | 29.93 | 111.03 | 876.6 | 1,532 | 1,482 | Upgrade
|
| Prepaid Expenses | 6.97 | 9.35 | 18.85 | 43.3 | 83.18 | Upgrade
|
| Other Current Assets | 82.93 | 15.4 | 77.87 | 218.98 | 609.84 | Upgrade
|
| Total Current Assets | 5,321 | 9,280 | 11,332 | 16,733 | 31,902 | Upgrade
|
| Property, Plant & Equipment | - | 1,186 | 2,595 | 3,691 | 4,361 | Upgrade
|
| Long-Term Investments | 150,581 | 148,404 | 126,236 | 116,798 | 232,141 | Upgrade
|
| Other Intangible Assets | - | 190.82 | 649.38 | 510.97 | 462.59 | Upgrade
|
| Long-Term Accounts Receivable | 3,784 | 2,940 | 2,130 | 3,486 | 4,363 | Upgrade
|
| Other Long-Term Assets | 306.58 | 729.27 | 2,762 | 3,064 | 1,245 | Upgrade
|
| Total Assets | 159,993 | 162,730 | 145,704 | 144,284 | 274,475 | Upgrade
|
| Accounts Payable | 273.03 | 684.25 | 317.9 | 308.8 | 646.11 | Upgrade
|
| Accrued Expenses | 286.38 | 403.38 | 401.12 | 346.01 | 605.07 | Upgrade
|
| Short-Term Debt | 500 | - | - | 934.13 | 11,631 | Upgrade
|
| Current Portion of Leases | 241.4 | 227.03 | 263.69 | 286.9 | 714.79 | Upgrade
|
| Other Current Liabilities | 560.79 | 802.02 | 1,131 | 1,934 | 14,246 | Upgrade
|
| Total Current Liabilities | 1,862 | 2,117 | 2,114 | 3,810 | 27,843 | Upgrade
|
| Long-Term Leases | 426.36 | 667.76 | 329.57 | 553.26 | 1,064 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 16,953 | Upgrade
|
| Other Long-Term Liabilities | 61.91 | 109.11 | 176.96 | 484.99 | 660.23 | Upgrade
|
| Total Liabilities | 2,350 | 2,894 | 2,621 | 4,848 | 46,521 | Upgrade
|
| Common Stock | 5,022 | 5,022 | 5,022 | 70,442 | 26,698 | Upgrade
|
| Additional Paid-In Capital | 136,123 | 136,123 | 136,123 | 141,607 | 139,272 | Upgrade
|
| Retained Earnings | 18,455 | 20,070 | 3,935 | -102,829 | 14,389 | Upgrade
|
| Treasury Stock | -2,448 | -2,448 | -2,448 | -2,385 | -2,385 | Upgrade
|
| Comprehensive Income & Other | 490.51 | 1,069 | 449.87 | 48.4 | 48.4 | Upgrade
|
| Total Common Equity | 157,643 | 159,836 | 143,083 | 106,884 | 178,022 | Upgrade
|
| Shareholders' Equity | 157,644 | 159,837 | 143,083 | 139,436 | 227,954 | Upgrade
|
| Total Liabilities & Equity | 159,993 | 162,730 | 145,704 | 144,284 | 274,475 | Upgrade
|
| Total Debt | 1,168 | 894.79 | 593.26 | 1,774 | 13,410 | Upgrade
|
| Net Cash (Debt) | -266.07 | 4,821 | 5,496 | 7,515 | 9,742 | Upgrade
|
| Net Cash Growth | - | -12.27% | -26.87% | -22.85% | -86.88% | Upgrade
|
| Net Cash Per Share | - | 482.88 | 645.77 | 2072.63 | 3260.05 | Upgrade
|
| Filing Date Shares Outstanding | - | 9.98 | 9.98 | 6.99 | 2.62 | Upgrade
|
| Total Common Shares Outstanding | - | 9.98 | 9.98 | 6.99 | 2.62 | Upgrade
|
| Working Capital | 3,460 | 7,164 | 9,218 | 12,924 | 4,059 | Upgrade
|
| Book Value Per Share | - | 16007.99 | 14330.10 | 15287.73 | 68023.15 | Upgrade
|
| Tangible Book Value | 157,643 | 159,645 | 142,433 | 106,373 | 177,560 | Upgrade
|
| Tangible Book Value Per Share | - | 15988.88 | 14265.07 | 15214.65 | 67846.39 | Upgrade
|
| Machinery | - | 566.08 | 1,067 | 1,123 | 1,073 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.